23.3 C
Thursday, September 29, 2022

What Is Known About Sexual Dysfunction After Breast Cancer?

Among women with breast cancer, sexual dysfunction often predates the cancer diagnosis and worsens in the following 2 years, according to an analysis of prospective data. Medscape Medical News

'Dubious' Benefit of Abemaciclib in Early Breast Cancer

With no overall survival benefit thus far, plus other concerns, editorialists "urge caution" before accepting abemaciclib as a standard of care in early breast cancer without mature data. Medscape Medical News

Genetic Tests Create Opportunities and Confusion for BRCA Patients

Doctors are divided on whether blanket testing of breast cancer patients is warranted, since scientists and physicians are sometimes unsure about how to interpret the results. Kaiser Health News

Sex Is Still a Taboo Subject for Patients With Breast Cancer

Many women with breast cancer say that their diagnosis has had a negative effect on their sex life. But few of these women consider consulting a sexologist. Medscape Medical News

FDA Warns of Cancer Risk in Scar Tissue Around Breast Implants

The warning comes after reports of patients with squamous cell carcinoma or various lymphomas around breast implant scar tissue, but the risk remains rare. Medscape Medical News

Healthy Habits Linked to Lower Cancer Risk in Minority Women

Black and Latina women who follow guidelines on nutrition and physical activity have a lower risk of developing breast, colorectal, and other obesity-related cancers. Medscape Medical News

Stronger Evidence That Exercise Lowers Breast Cancer Risk

The methodology of a new study provides stronger evidence of a causal association between physical activity levels and breast cancer risk than has been reported from observational studies Medscape Medical News

Time to Pull Back on Postsurgery Radiation in Breast Cancer?

A new study suggests that oncologists can safely pull back on standard locoregional radiotherapy in select patients with cT1-2N1 breast cancer who are treated with primary chemotherapy prior to surgery. MDedge News

Atorvastatin Improves Cisplatin Sensitivity in Breast Cancer Cells

The findings suggest targeting cholesterol metabolism as adjuvant therapy for platinum-based chemotherapy in breast cancer. The study was published as a preprint and has not yet been peer reviewed. First Look

Which Breast Cancer Type Has Greatest Risk of Brain Metastasis?

New research indicates that patients with metastatic ERBB2-positive disease and triple-negative breast cancer face the greatest risk. This data may help inform screening for brain metastases.

 Medscape Medical News

Time Management Tips


clear sky
23.3 ° C
24.5 °
21.2 °
70 %
0 %
28 °
28 °
31 °
34 °
24 °

Must Read